3. Wang X, Wang Z, et al. Efficacy and safety of dapsone gel for acne: a systematic review and meta-analysis. Ann Palliat Med. 2022 Feb;11(2):611-620. doi: 10.21037/apm-21-3935. PMID: 35249339.
4. MIMS. Dapsone. 2023. https://www.mims.com/indonesia/drug/info/dapsone?mtype=generic
5. Australian Product Information. Dapsone tablet. TGA. 2019. https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2010-PI-03339-3&d=202009021016933
9. Highlight of Prescribing Information Dapsone Gel 7,5%. FDA. 2016. https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/207154s000lbl.pdf
12. Consumer Medicine Information (CMI) Summary. Dapsone. March 2022. https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2010-CMI-03340-3
14. World Health Organization. MDT: duration of treatment FAQ. 2020.https://www.who.int/lep/mdt/duration/en/
15. Panduan Praktik Klinis. Perhimpunan Dokter Spesialis Kulit dan Kelamin Indonesia (PERDOSKI). 2017. Hal.80-88
16. Peraturan Menteri Kesehatan Republik Indonesia No 11 tahun 2019 tentang Penanggulangan Kusta. http://hukor.kemkes.go.id/uploads/produk_hukum/PMK_No__11_Th_2019_ttg_Penanggulangan_Kusta.pdf
17. Australian Product Information. Dapsone 7,5% Gel. January 2021. https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2017-PI-01103-1